Shares of SpaceX (SPCX) are currently changing hands at $147.95, representing a decline of roughly 34% from the 52-week peak of $225.64. Despite this pullback, Wall Street sentiment continues to strengthen around the aerospace giant. Pivotal Research recently became the newest firm to launch coverage, assigning a Buy recommendation alongside a $220 valuation target.
Space Exploration Technologies Corp., SPCX
Pivotal’s investment rationale centers on a critical question: can SpaceX achieve meaningful Starship reusability? The firm’s analysis specifically targets 20 to 50 missions per spacecraft with economical and rapid turnaround maintenance. Their analyst characterized this as “a single admittedly massive engineering bottleneck.” Success unlocks tremendous value potential. Failure transforms SpaceX into what they described as “a different and much smaller company.”
This represents a significant wager on an equity that currently commands a $2.01 trillion market capitalization.
Recent quarterly performance provided ammunition for optimistic investors. Revenue reached $7.81 billion, representing 91.9% year-over-year expansion, while the loss per share of -$0.09 exceeded analyst expectations of -$0.26 by $0.17. Over the trailing twelve months, the company delivered $23 billion in total revenue with gross margins approaching 52%.
SpaceX continues operating at a loss, however, with trailing twelve-month losses of $2.27 per share.
Assuming SpaceX cracks the Starship reusability challenge, Pivotal outlined numerous expansion opportunities. The roadmap includes expanding Starlink’s capabilities to capture portions of the $1.7 trillion terrestrial and wireless communications market, launching orbital computing facilities that circumvent ground-based electrical infrastructure limitations, and serving neocloud and hyperscale computing clients.
Additional revenue opportunities identified by the firm include suborbital point-to-point passenger transportation, manufacturing operations in space, defense contracts such as the Golden Dome initiative, and space-based energy transmission capabilities arriving by 2030.
Pivotal isn’t alone in its enthusiasm. Arete Research maintains a $450 valuation target, Oppenheimer elevated its forecast to $280, and Bernstein SocGen reaffirmed its Outperform stance with a $248 objective. The consensus price target among covering analysts stands at $221.20, with an overall “Moderate Buy” rating.
Both Goldman Sachs and Guggenheim maintain Buy recommendations. Roth Capital elevated the stock to Buy status in June.
The outlook isn’t uniformly positive. Market participants are closely monitoring September 9, when a share lockup expires. Fresh supply from insiders and early investors entering the market may generate downward pressure, particularly following the stock’s recent upward movement.
Capital expenditure levels also raise questions. Reports indicate SpaceX invested $18.4 billion during a single quarter, with $15.8 billion allocated to artificial intelligence initiatives. Skeptics contend the stock’s multitrillion-dollar valuation already incorporates substantial future achievement.
Institutional investors continue accumulating positions despite concerns. Compass Financial Management established a fresh position valued at $1.63 million during Q2, joining numerous smaller investment firms initiating holdings.
Starship Test 14 draws nearer, with a possible launch window opening in mid-September. A successful demonstration would serve as a significant positive catalyst for shares.
The post SpaceX (SPCX) Stock Could Surge 49% According to Pivotal Research Analysis appeared first on Blockonomi.
